Available Forms: Tablets
Available Strengths: 35 mg
Reference Brands: Vastarel MR (EU), Vastarel (UK)
Category: Heart Disorder
Trimetazidine is a metabolic agent used in cardiology to improve heart function. It works by optimizing myocardial energy metabolism, helping the heart use glucose more efficiently under conditions of low oxygen. Trimetazidine is commonly prescribed for angina pectoris (chest pain due to reduced blood flow to the heart) and may be used as an adjunct therapy in patients with chronic stable angina. Trimetazidine is available in Tablets and strengths such as 35 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Trimetazidine is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Trimetazidine can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Quick Response Guaranteed | Verified Suppliers
Strength: 0.5 mg, 1 mg, 2 mg
Form: Tablets
Reference Brands: Mavik (USA), Gopten (EU)
Strength: 2.5 mg/mL
Form: Injection
Reference Brands: Aggrastat (USA)
Strength: 200 mcg, 400 mcg, 600 mcg, 800 mcg, 1000 mcg, 1200 mcg, 1400 mcg, 1600 mcg
Form: Tablets / Injection
Reference Brands: Uptravi (USA/EU)
Strength: 15 mg, 30 mg, 60 mg
Reference Brands: Savaysa (USA), Lixiana (EU)
By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under ‘Fair use.’
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Stay updated on pharma trends and marketplace opportunities.